DunlaySM, StrandJJ, WordinghamSE, et al.: Dying with a left ventricular assist device as destination therapy. Circ Heart Fail, 2016; 9:e003096.
2.
MehraMR, UrielN, NakaY, et al.: A fully magnetically levitated left ventricular assist device—Final report. N Engl J Med, 2019; 380:1618–1627.
3.
KirklinJK, PaganiFD, KormosRL, et al.: Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant, 2017; 36:1080–1086.
4.
McIlvennanCK, MagidKH, AmbardekarAV, et al.: Clinical outcomes after continuous-flow left ventricular assist device: A systematic review. Circ Heart Fail, 2014; 7:1003–1013.
5.
McIlvennanCK, GradyKL, MatlockDD, et al.: End of life for patients with left ventricular assist devices: Insights from INTERMACS. J Heart Lung Transplant, 2019; 38:374–381.
6.
McIlvennanCK, JonesJ, AllenLA, et al.: Bereaved caregiver perspectives on the end-of-life experience of patients with a left ventricular assist device. JAMA Intern Med, 2016; 176:534.
7.
NakagawaS, AndoM, TakayamaH, et al.Withdrawal of left ventricular assist devices: A retrospective analysis from a single institution. J Palliat Med, 2019 [Epub ahead of print]; DOI: 10.1089/jpm.2019.0322.
8.
SwetzKM, CookKE, OttenbergAL, et al.: Clinicians' attitudes regarding withdrawal of left ventricular assist devices in patients approaching the end of life. Eur J Heart Fail, 2013; 15:1262–1266.
9.
MuellerPS, SwetzKM, FreemanMR, et al.: Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc, 2010; 85:791–797.
10.
RadyMY, VerheijdeJL: Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: Left ventricular assist devices and total artificial hearts. J Intensive Care Med, 2014; 29:3–12.
11.
SchaeferKG, GriffinL, SmithC. An interdisciplinary checklist for left ventricular assist device deactivation. J Palliat Med, 2014; 17:4–5.
12.
JabreP, BelpommeV, AzoulayE, et al.: Family presence during cardiopulmonary resuscitation. N Engl J Med, 2013; 368:1008–1018.
